FDA allows IND application for AV-001 in hospitalized patients with COVID-19 Nov. 13, 2020 No Comments
Phase III NAVIGATOR study of tezepelumab in severe asthma meets primary endpoint Nov. 10, 2020 No Comments
AstraZeneca reports data from steroid-sparing trial of Fasenra in severe asthma Nov. 2, 2020 No Comments
Boehringer Ingelheim initiates phase II study of BI-764198 in patients with COVID-19 Oct. 29, 2020 No Comments
RSS